anti rejection for grafts: anti-IL2 Receptor antibody

in #science7 years ago (edited)

One of the most 15 last years and current very efficacious treatments for anti-rejection of the grafts is anti-IL2Receptor (anti-IL2R) .

Targeting the lymphocyte T, these antibodies are able to stop the activation of the lymphocyte T, which is the effector of the rejection phenomenon.
Basiliximab_MdA.jpg

Efficacy of transplantation for kidney grafts is nowadays better and better, but it is still dependent on the graft quality
state-of-pediatric-kidney-transplantation-16-728.jpg

Coin Marketplace

STEEM 0.28
TRX 0.13
JST 0.032
BTC 65920.41
ETH 3016.79
USDT 1.00
SBD 3.71